Blog Archives for tag Nintedanib

Press Release – Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease

Today, Boehringer Ingelheim sent out a press release, announcing that, “…┬áthe European Commission (EC) and U.S. Food and Drug Administration… Continue reading »